Warren Buffett, the investment virtuoso with a net worth of more than $84 billion, once again criticized bitcoin. This time, however, he used a more intense description.
“[P]robably rat poison squared,” the Berkshire Hathaway CEO was quoted by CNN Money as saying before the annual stockholders’ meeting of his company last Saturday. This remark was backed by Berkshire vice chairman Charlie Munger, saying that trading in the virtual space is “just dementia.”
Renowned as the “Oracle of Omaha,” Buffett expressed his skepticism about cryptocurrency a few years back, describing it as a “mirage.” According to CCN, he said the system is a “joke,” likening that to putting some value to checks just because they are used to transmit money.
“In terms of cryptocurrencies, generally, I can almost say with certainty that they will come to a bad ending,” Buffett was quoted by the CCN report. He even stated that he would wager on all of the cryptocurrencies slipping over the next five years, although he also said, “I would never short a dime’s worth.”
Buffett also shared in December his opinion about initial coin offerings (ICOs), saying that they will not beef up investments. Citing data from CoinSchedule, CCN said ICOs in 2017 generated over $3.2 billion.
The business magnate also said bitcoin investing is more like speculating—which, he thinks, is no different from gambling.
The aforementioned CNN Money article reported that some cryptocurrency experts should not pay attention to the criticisms of Munger and Buffett. deVere Group CEO Nigel Green said in a report that he is perplexed about the two men not seeing “the intrinsic value of some form of cryptocurrency.”
Additionally, Zhao Changpeng, the CEO of cryptocurrency exchange company Binance, said, “Warren Buffett is a guy I truly respect from an investment point of view, but I do not think he understands cryptocurrencies at all.” He also added that Buffett “is making a big mistake” on cryptocurrencies.
Microsoft founder Bill Gates also chimed in on the issue, sharing Buffett’s and Munger’s opinions towards bitcoin. A Bitsonline article wrote that in an interview with CNBC, he said he’d “short” it “if there was an easy way to do it.” He also stated that these digital currencies “caused deaths in a fairly direct way.”
After Buffett’s and Gates’ criticisms on bitcoin, prices of cryptocurrencies experienced a drop on Tuesday, Yahoo! Finance reported.
Bitcoin, which is getting closer to the $10,000 levels, fell 1.2 percent on the Bitfinex exchange, arriving at $9,431.6. On the other hand, Ethereum declined by 3.5 percent and traded at $754.03. Litecoin and XRP also plummeted, with the former 1.9 percent lower at $166.02 and the latter dropping three percent to $0.83106 on the Poloniex exchange.
BlackRock Launches First Liquid ESG Equity Alternative Fund in Europe
The Systematic ESG Equity Absolute Return Fund (SEEAR) alunched by BlackRock is designed for Liquid Alternatives investors seeking a global...
El Cesar has the Conditions to Enter the Medical Cannabis Market in Colombia
Municipalities such as San Alberto, San Martin, Gonzalez, among others, have the conditions to grow medical cannabis, a bet of...
Analysts Forecast a Bitcoin Price Between $51,000 and $1 Million
if you look at the Bitcoin price forecasts of other well-known faces from the crypto industry, Alfred is not alone...
Forget Facebook (NASDAQ: FB) and Apple (NASDAQ: AAPL): Virtual Reality (VR) and Augmented Reality (AR) Investors Should Snap Up XRApplied (CSE: XRA) Instead
It’s no secret that AR, VR, and MR are hot investments right now. Facebook’s throwing the weight of 10,000 full-time...
PagaPhone Seeks to Facilitate Remittance Collection and Boost Financial Inclusion in Mexico
PagaPhone, which already has pre-authorization from the National Banking and Securities Commission to operate as an electronic payment fund institution,...
Biotech7 days ago
UrbanFisio Launches Virtual Assistant to Surpass €1 Million by 2021
Business6 days ago
Nine Ways to Make Your Blog More Engaging
Biotech5 days ago
Claris Ventures, €85 Million Closing for the Turin-based Sgr Focused on Early-Stage Biotech
Featured4 days ago
Why Gold Continues to Struggle